In vitro evaluation of the antifungal efficacy of poloxamer 407-based formulations in an infected nail plate model.

[1]  O. Sammour,et al.  Novel nail penetration enhancer containing vesicles “nPEVs” for treatment of onychomycosis , 2016, Drug delivery.

[2]  F. C. Flores,et al.  Essential Oils for Treatment for Onychomycosis: A Mini-Review , 2015, Mycopathologia.

[3]  C. Müller-Goymann,et al.  In vitro permeation and penetration of ciclopirox olamine from poloxamer 407-based formulations--comparison of isolated human stratum corneum, bovine hoof plates and keratin films. , 2015, International journal of pharmaceutics.

[4]  Chandrakantsing V. Pardeshi,et al.  Insights into drug delivery across the nail plate barrier , 2014, Journal of drug targeting.

[5]  Lusiana,et al.  Infected nail plate model made of human hair keratin for evaluating the efficacy of different topical antifungal formulations against Trichophyton rubrum in vitro. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[6]  C. Grover,et al.  An update on treatment of onychomycosis , 2012, Mycoses.

[7]  Lusiana,et al.  Keratin film made of human hair as a nail plate model for studying drug permeation. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[8]  S. Murdan.  Enhancing the nail permeability of topically applied drugs , 2008, Expert opinion on drug delivery.

[9]  S. Murdan.  Drug delivery to the nail following topical application. , 2002, International journal of pharmaceutics.

[10]  B. Elewski,et al.  A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns. , 2000, Journal of the American Academy of Dermatology.

[11]  R. Summerbell,et al.  Prevalence and epidemiology of onychomycosis in patients visiting physicians' offices: a multicenter canadian survey of 15,000 patients. , 2000, Journal of the American Academy of Dermatology.

[12]  E. Haneke,et al.  The scope of onychomycosis: epidemiology and clinical features , 1999, International journal of dermatology.

[13]  J. Zatz,et al.  Structural characteristics and permeability properties of the human nail : A review , 1999 .

[14]  G. Faich,et al.  Effect of onychomycosis on quality of life. , 1998, Journal of the American Academy of Dermatology.

[15]  B. Lippold,et al.  In‐vitro Permeability of the Human Nail and of a Keratin Membrane from Bovine Hooves: Prediction of the Penetration Rate of Antimycotics through the Nail Plate and their Efficacy , 1997, The Journal of pharmacy and pharmacology.

[16]  B. Lippold,et al.  In‐vitro Permeability of the Human Nail and of a Keratin Membrane from Bovine Hooves: Influence of the Partition Coefficient Octanol/Water and the Water Solubility of Drugs on their Permeability and Maximum Flux , 1997, The Journal of pharmacy and pharmacology.

[17]  G. Piérard,et al.  Treatment of onychomycosis: traditional approaches. , 1993, Journal of American Academy of Dermatology.